Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Apoptosis
    (1)
  • CDK
    (1)
  • Endogenous Metabolite
    (1)
  • P2Y Receptor
    (1)
  • PROTACs
    (1)
  • c-Myc
    (1)
  • Others
    (2)
TargetMol | Tags By ResearchField
  • Cancer
    (2)
  • Cardiovascular System
    (1)
  • Inflammation
    (1)
  • Respiratory System
    (1)
Filter
Search Result
Results for "

T8393

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    2
    TargetMol | All_Pathways
  • PROTAC Products
    1
    TargetMol | PROTAC
  • Natural Products
    1
    TargetMol | Natural_Products
LL-K9-3
T839362809353-52-2
LL-K9-3, a selective hydrophobic tagging technology (HyT)-based degrader, specifically targets the CDK9-cyclin T1 complex, displaying DC50 values of 589 nM for cyclin T1 and 662 nM for CDK9. This compound consists of the CDK9 inhibitor, SNS 032, linked to a hydrophobic tag via a glycol linker. Notably, LL-K9-3 does not affect the degradation of other CDKs (CDK1, 2, 4, 5, 6, and 7). Tested in 22RV1 cells, it effectively reduces androgen receptor (AR) and cMyc expression by inducing the selective and synchronous degradation of CDK9 and cyclin T1.
  • $1,280
35 days
Size
QTY